Elevance Health, Inc. (NYSE:ELV) to Issue Quarterly Dividend of $1.72

Elevance Health, Inc. (NYSE:ELV) announced a quarterly dividend on Tuesday, October 20th. Shareholders of record on Friday, December 4th will be given a dividend of $1.72 per share on Friday, December 18th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, December 4th.

Elevance Health has increased its dividend payment by an average of 0.1% per year over the last three years and has increased its dividend every year for the last 14 years. Elevance Health has a payout ratio of 17.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Elevance Health to earn $29.41 per share next year, which means the company should continue to be able to cover its $6.88 annual dividend with an expected future payout ratio of 23.4%.

Elevance Health Stock Performance

Shares of NYSE ELV traded down $4.92 during midday trading on Wednesday, hitting $435.26. 2,474,569 shares of the company’s stock traded hands, compared to its average volume of 1,606,289. Elevance Health has a 1 year low of $274.84 and a 1 year high of $450.69. The stock has a market capitalization of $94.39 billion, a price-to-earnings ratio of 19.34, a price-to-earnings-growth ratio of 2.24 and a beta of 0.70. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.52 and a current ratio of 1.52. The firm has a fifty day moving average of $405.84 and a 200 day moving average of $388.57.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, topping the consensus estimate of $4.71 by $2.28. The firm had revenue of $50.44 billion for the quarter, compared to analysts’ expectations of $49.22 billion. Elevance Health had a net margin of 2.47% and a return on equity of 14.64%. The business’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.03 EPS. On average, analysts forecast that Elevance Health will post 27.20 earnings per share for the current year.

More Elevance Health News

Here are the key news stories impacting Elevance Health this week:

• Positive Sentiment: Elevance reported adjusted earnings of $6.99 per share, substantially above estimates of roughly $4.66–$4.71 and ahead of $6.03 a year earlier. Revenue reached $50.44 billion, also exceeding expectations of $49.22 billion. Elevance Health Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: The company raised its 2026 earnings outlook, citing stronger execution, better medical-cost management and the strength of its diversified businesses. Management established a higher 2026 underlying earnings baseline of at least $26.75 per share and expects at least 12% adjusted EPS growth in 2027 from that base. Elevance Health Reports Third Quarter Results and Raises Guidance
• Positive Sentiment: Carelon was a key growth driver despite pressure in the insurance membership business, supporting the company’s strategy of expanding higher-value healthcare services beyond traditional health plans. ELV Beats Q3 Earnings Estimates on Carelon Strength
• Neutral Sentiment: Elevance appointed Jeff Park as Carelon president, effective December 1, 2026. The leadership change is intended to support Carelon’s next phase of growth, although its financial impact will depend on execution. Elevance Health Names Jeff Park President of Carelon
• Negative Sentiment: Medical membership declined, highlighting potential pressure on premium revenue and future growth. Investors may also remain focused on whether medical-cost trends remain manageable after the quarter’s improvement. Elevance Lifts 2026 Profit Forecast

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.